Abstract
Introduction: Acetylcholinesterase enzyme (AChE) is the main target in Alzheimer's disease therapy and designing of novel AChE inhibitors is a great deal of attention.
Methods: In this study, 2D-QSAR and 3D-QSAR models were generated using stepwise multiple linear regressions (SW-MLR) and comparative molecular field analysis (CoMFA) respectively.
Results: It was found that CoMFA model with r2 of 0.947 for the training set and r2 of 0.816 for the test set is more favorable than model which is established by SW-MLR method with r2 =0.825 and r2pred =0.778 in 2D-QSAR.
Conclusion: In addition, obtaining models were validated by cross validation with cut off values of q2 > 0.5 and r2pred > 0.6.
Keywords: Acetylcholinesterase, SW-MLR, CoMFA, QSAR, Enzyme, Piperazine.
Current Computer-Aided Drug Design
Title:2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors
Volume: 14 Issue: 4
Author(s): Maryam Nazari, Sayyed Abbas Tabatabai and Elham Rezaee*
Affiliation:
- Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran,Iran
Keywords: Acetylcholinesterase, SW-MLR, CoMFA, QSAR, Enzyme, Piperazine.
Abstract: Introduction: Acetylcholinesterase enzyme (AChE) is the main target in Alzheimer's disease therapy and designing of novel AChE inhibitors is a great deal of attention.
Methods: In this study, 2D-QSAR and 3D-QSAR models were generated using stepwise multiple linear regressions (SW-MLR) and comparative molecular field analysis (CoMFA) respectively.
Results: It was found that CoMFA model with r2 of 0.947 for the training set and r2 of 0.816 for the test set is more favorable than model which is established by SW-MLR method with r2 =0.825 and r2pred =0.778 in 2D-QSAR.
Conclusion: In addition, obtaining models were validated by cross validation with cut off values of q2 > 0.5 and r2pred > 0.6.
Export Options
About this article
Cite this article as:
Nazari Maryam , Tabatabai Abbas Sayyed and Rezaee Elham *, 2D & 3D-QSAR Study on Novel Piperidine and Piperazine Derivatives as Acetylcholinesterase Enzyme Inhibitors, Current Computer-Aided Drug Design 2018; 14 (4) . https://dx.doi.org/10.2174/1573409914666180726092800
DOI https://dx.doi.org/10.2174/1573409914666180726092800 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effects of Exercise on Postpartum Weight Retention in Overweight and Obese Women
Current Women`s Health Reviews Assessing Glutamatergic Function and Dysfunction in Peripheral Tissues
Current Medicinal Chemistry Evoked Potential in Panic Disorder Patients: A Systematic Review
CNS & Neurological Disorders - Drug Targets Xenobiotic-Metabolizing Enzymes in Human Lung
Current Drug Metabolism Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Health Service Utilization and Costs of Depressive Symptoms in Late Life - A Systematic Review
Current Pharmaceutical Design Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives
Current Neuropharmacology The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators
CNS & Neurological Disorders - Drug Targets PET Radiopharmaceuticals for Personalized Medicine
Current Drug Targets miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion
Current Neurovascular Research The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Structure and Function of Small Non-Peptide CRF Antagonists and their Potential Clinical Use
Current Molecular Pharmacology Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives
Current Drug Metabolism Immunotherapy for Malignant Melanoma Robert
Current Stem Cell Research & Therapy IAPs, their Antagonists and their Role in Neurological Disease and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Diagnosis, Treatment, and New Developments in Preeclampsia
Current Women`s Health Reviews The Immunocompromised Host: Immune Alterations in Splenectomized Patients and Clinical Implications
Current Pharmaceutical Design Cannabis: A Neurological Remedy or a Drug of Abuse in India
CNS & Neurological Disorders - Drug Targets Downstream Processing for Production of Value Added Products from Coconut
Current Biochemical Engineering (Discontinued) Features and Factors Associated with Drinking Problems or Illegal Drugs Use: A Cross Sectional Cohort Study with Patients of a Psychosocial Care Service
Applied Clinical Research, Clinical Trials and Regulatory Affairs